Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
Sensors (Basel, Switzerland)|January 8, 2025
Analyzing and Modeling the Dynamic Electrical Characteristics of Nanocomposite Large-Range Strain GaugesAlex M Wonnacott, Anton E Bowden, Ulrike H Mitchell, et al.
Annals of Biomedical Engineering|July 25, 2022
Best Practices for Conducting Physical Reconstructions of Head Impacts in SportJames R Funk, Andrew S McIntosh, Chris Withnall, et al.
Neuropharmacology|May 24, 2003
Attentional effects of nicotinic agonists in ratsBritta Hahn, Christopher G V Sharples, Susan Wonnacott, et al.
Cell Stem Cell|February 11, 2014
MSC-based product characterization for clinical trials: an FDA perspectiveMichael Mendicino, Alexander M Bailey, Keith Wonnacott, et al.
Journal of Psychopharmacology (Oxford, England)|March 11, 2021
Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatementJosephine Palandri, Sharon L Smith, David J Heal, et al.
Critical Care Nursing Quarterly|December 11, 2012
Extending the benefits of early mobility to critically ill patients undergoing continuous renal replacement therapy: the Michigan experienceCheryl L Talley, Robert O Wonnacott, Janice K Schuette, et al.
Drug Discovery Today|December 27, 2005
From ligand design to therapeutic efficacy: the challenge for nicotinic receptor researchBruce K Cassels, Isabel Bermúdez, Federico Dajas, et al.
Journal of Neurochemistry|March 7, 1998
Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slicesS A Kaiser, L Soliakov, S C Harvey, et al.
Nephrology (Carlton, Vic.)|October 10, 2015
The impact of acute kidney injury in diabetes mellitusFaye Johnson, Dafydd Phillips, Bnar Talabani, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sitesK L Swanson, R S Aronstam, S Wonnacott, et al.
Pageof 23